These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 12640315)

  • 1. Human leukocyte antigens DR and AB and kidney retransplantation.
    Thompson JS; Thacker LR; Krishnan G
    Transplantation; 2003 Mar; 75(5):718-23. PubMed ID: 12640315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated HLA mismatches and second renal graft survival in centers of the South-Eastern Organ Procurement Foundation.
    Heise ER; Thacker LR; MacQueen JM; Peters TG
    Clin Transplant; 1996 Dec; 10(6 Pt 2):579-85. PubMed ID: 8996746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeating HLA antigen mismatches in renal retransplants--a second class mistake?
    Cecka JM; Terasaki PI
    Transplantation; 1994 Feb; 57(4):515-9. PubMed ID: 8116035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing role of HLA matching.
    Cecka JM
    Clin Transpl; 1986; ():141-55. PubMed ID: 3154392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regraft kidney transplant survival.
    Cicciarelli J; Cho RY
    Clin Transpl; 1986; ():285-97. PubMed ID: 3154419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does re-exposure to mismatched HLA antigens decrease renal re-transplant allograft survival?
    Farney AC; Matas AJ; Noreen HJ; Reinsmoen N; Segall M; Schmidt WJ; Gillingham K; Najarian JS; Sutherland DE
    Clin Transplant; 1996 Apr; 10(2):147-56. PubMed ID: 8664509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA matching effect on five-year graft survival and half-life in the cyclosporine era.
    Mitsuishi Y; Terasaki PI
    Kidney Int Suppl; 1992 Oct; 38():S172-5. PubMed ID: 1405371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
    House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
    Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
    Duquesnoy RJ; Howe J; Takemoto S
    Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A; Backman L; Jennings L; Levy MF; Goldstein R; Gonwa T; Stone MJ; Klintmalm G
    Transplantation; 1994 Oct; 58(7):786-92. PubMed ID: 7940711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of human leukocyte antigen matching on transplant complications and immunosuppression dosage.
    Aydingoz SE; Takemoto SK; Pinsky BW; Salvalaggio PR; Lentine KL; Willoughby L; Hoover B; Burroughs TA; Schnitzler MA; Graff R
    Hum Immunol; 2007 Jun; 68(6):491-9. PubMed ID: 17509448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA matching: univariate and multivariate analyses of UNOS Registry data.
    Cicciarelli J; Cho Y
    Clin Transpl; 1991; ():325-33. PubMed ID: 1820128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
    Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
    Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent improvements in cadaver-donor kidney retransplantation.
    Mitsuishi Y; Cecka JM
    Clin Transpl; 1991; ():281-91. PubMed ID: 1820123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
    Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
    Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.
    Hwang SH; Oh HB; Shin ES; Yew M; Kim SC; Han DJ
    Transplant Proc; 2005 Dec; 37(10):4194-8. PubMed ID: 16387076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREG matching for first cadaveric kidney transplants (TNX) performed by SEOPF centers between October 1987 and September 1995. Southeastern Organ Procurement Foundation.
    Thompson JS; Thacker LR
    Clin Transplant; 1996 Dec; 10(6 Pt 2):586-93. PubMed ID: 8996747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.